Title : Efficacy and tolerability of novel triple combination therapy in drug-naïve patients with type 2 diabetes from the TRIPLE-AXEL trial: protocol for an open-label randomised controlled trial.

Pub. Date : 2018 Sep 24

PMID : 30249630






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We aim to evaluate the efficacy and tolerability of a novel, initial triple combination therapy with metformin, sodium glucose cotransporter 2 inhibitor (dapagliflozin) and dipeptidyl peptidase-4 inhibitor (saxagliptin) compared with conventional stepwise add-on therapy in drug-naive patients with recent-onset type 2 diabetes. saxagliptin dipeptidyl peptidase 4 Homo sapiens